Skip to main content
Caplight Logo









GRASSMEDI

GRASSMEDI

Private
Mungyeong-siHealthcare & Life Scienceshttps://grassmedi.com/

Last Round

Grant

Jul 1, 2023

Total Funding Raised

$1.24M

Company Overview

GRASSMEDI is a pet biotechnology company that provides total healthcare solutions for pets and their owners.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, D2C Brands, E-commerce

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

pet care productspet biotechnologyD2C pet brandpet wellnessanimal healthveterinarian formulatedpet oral carepet dental carepet skin caree-commercepet techB2B sales

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GRASSMEDI Comparables

Compare GRASSMEDI with similar companies based on industry and business-model similarity.

GRASSMEDI comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kin + Kind
80%
Skout's Honor
79%
Petsmile
79%

GRASSMEDI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 1, 2023
SeedApr 1, 2023
Pre SeedApr 1, 2022
CrowdfundingAug 28, 2020

Key People

Founding team and executive leadership

Jinsik Choi

Chief Executive Officer

Executive Team

GRASSMEDI Investors

Notable investors and investment history

GRASSMEDI investors
InvestorRounds
Atinum VenturesSeed
ActnerLabPre Seed
FuturePlaySeed
Tech Incubator Program for StartupsGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2023

    $390K grant received from Tech Incubator Program for Startups.

  • Apr 1, 2023

    $730K raised from Atinum Ventures and FuturePlay.

GRASSMEDI Filings

Explore SEC and related filing metadata, where available.

GRASSMEDI filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about GRASSMEDI's valuation, stock price, and market status.

Is GRASSMEDI a public or private company?

GRASSMEDI is a private company.

What is the current stock price of GRASSMEDI?

GRASSMEDI is a private company with no public stock price. No recent secondary market data is available.

How much is GRASSMEDI worth (valuation)?

Valuation information for GRASSMEDI is not publicly available.

Can I buy GRASSMEDI stock?

GRASSMEDI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was GRASSMEDI's last funding round?

GRASSMEDI's most recent funding round was Grant on July 1, 2023.

Who are the main investors in GRASSMEDI?

Key investors in GRASSMEDI include ActnerLab.

Will GRASSMEDI IPO soon?

No public IPO plans have been announced for GRASSMEDI.

How can I track GRASSMEDI secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GRASSMEDI's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMungyeong-si
Employee Range6
Year Founded2019
Last FundingJul 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?